Xenon Pharmaceuticals Inc... (XENE)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

40.05

-0.05%

After-hours Dec 13, 2024, 05:19 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	-	9.43M	18.44M	32.17M	6.83M	-	311.00K	1.80M	15.58M	28.37M	27.36M	14.31M	6.92M
Cost of Revenue	167.51M	105.77M	75.46M	50.52M	38.84M	6.00M	25.57M	1.11M	2.76M	5.90M	6.21M	7.32M	-
Gross Profit	-167.51M	-96.33M	-57.03M	-18.36M	-32.02M	-6.00M	-25.26M	689.00K	12.81M	22.47M	21.15M	6.99M	6.92M
Operating Income	-214.05M	-129.14M	-78.99M	-31.30M	-42.82M	-38.02M	-32.58M	-24.82M	-9.36M	11.11M	9.71M	-3.15M	-12.11M
Interest Income	27.62M	8.71M	466.00K	2.28M	2.35M	1.22M	477.00K	504.00K	542.00K	568.00K	338.00K	144.00K	153.00K
Pretax Income	-182.69M	-125.25M	-78.89M	-29.09M	-41.62M	-34.50M	-30.70M	-23.00M	-15.75M	13.02M	12.03M	-4.30M	-11.99M
Net Income	-182.39M	-125.37M	-78.88M	-28.84M	-41.59M	-34.50M	-30.70M	-23.00M	-15.75M	13.02M	12.03M	-4.30M	-11.99M
Selling & General & Admin	46.54M	32.81M	21.97M	12.94M	10.80M	8.38M	7.31M	6.79M	9.79M	5.50M	5.34M	7.01M	6.73M
Research & Development	167.51M	105.77M	75.46M	50.52M	38.84M	23.63M	25.57M	19.83M	15.15M	11.77M	12.30M	10.46M	12.30M
Other Expenses	-167.51M	3.89M	105.00K	2.21M	-	4.40M	-	-	-6.39M	-	-	-	-
Operating Expenses	46.54M	138.58M	97.43M	63.47M	49.65M	32.02M	32.89M	26.62M	24.94M	17.26M	17.64M	17.46M	19.03M
Interest Expense	-	-	-	484.00K	1.43M	1.39M	-	-	-	-	64.00K	93.00K	91.00K
Selling & Marketing Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	214.05M	138.58M	97.43M	63.47M	49.65M	38.02M	32.89M	26.62M	24.94M	17.26M	17.64M	17.46M	19.03M
Income Tax	292.00K	118.00K	-6.00K	-257.00K	-23.00K	4.91M	-1.87M	-1.82M	-1.04M	-	64.00K	93.00K	91.00K
Shares Outstanding (Basic)	66.89M	60.54M	43.63M	34.54M	25.94M	19.43M	17.99M	15.49M	14.28M	3.17M	9.09M	9.09M	9.08M
Shares Outstanding (Diluted)	66.89M	60.54M	43.63M	34.54M	25.94M	19.43M	18.00M	15.49M	14.28M	3.96M	9.83M	9.83M	9.74M
EPS (Basic)	-2.73	-2.07	-1.81	-0.83	-1.6	-1.78	-1.71	-1.48	-1.1	4.11	0.42	-0.47	-1.32
EPS (Diluted)	-2.73	-2.07	-1.81	-0.83	-1.6	-1.78	-1.71	-1.48	-1.1	3.28	0.39	-0.44	-1.23
EBITDA	-210.51M	-127.52M	-78.09M	-27.97M	-39.76M	-32.54M	-30.05M	-23.95M	-8.32M	11.84M	10.42M	-3.42M	-10.77M
Depreciation & Amortization	3.54M	1.62M	906.00K	644.00K	429.00K	586.00K	649.00K	864.00K	1.04M	738.00K	705.00K	786.00K	1.13M